Belvedere Trading’s LeonaBio Inc LONA Stock Holding History

Belvedere Trading’s Portfolio LONA Stock Details LONA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,110	Closed	-$593K	–	371
2022 Q1	$593K	Sell	5,110 -619	-11%	-$65.3K	0.02%	89
2021 Q4	$573K	Buy	+5,729	New	+$724K	0.03%	93

Other funds holding LONA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 20.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Belvedere Trading's LONA Position: Q2 2022 in Review

Belvedere Trading sold out of LeonaBio Inc (LONA) in Q2 2022, closing a stake of 5,110 shares — an estimated $593K sold.

Belvedere Trading first reported a position in LONA in Q4 2021 and held it in 2 quarters. The position peaked at $593K in Q1 2022. 98 funds tracked by Wall St. Rank hold LONA as of Q2 2022.

Belvedere Trading reported no remaining LeonaBio Inc position as of Q2 2022 after selling out during the quarter.
Belvedere Trading sold 5,110 LeonaBio Inc shares in Q2 2022, an estimated $593K.
Belvedere Trading first reported a position in LeonaBio Inc in Q4 2021 and held it in 2 quarters.
Belvedere Trading's LeonaBio Inc position peaked at $593K in Q1 2022.
98 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2022.

Based on Belvedere Trading's 13F filing for Q2 2022, filed 21 Jul 2022.